Literature DB >> 2784750

Reactivity of normal rat epiphyseal chondrocytes with monoclonal antibodies recognizing different leucocyte markers.

J Malejczyk1, A Romaniuk.   

Abstract

The aim of the study was to test whether normal rat epiphyseal chondrocytes react with monoclonal antibodies (MoAbs) detecting different markers of lymphoid cells. For this purpose, isolated chondrocyte and, for comparison, splenocyte cytosmears were exposed to a battery of different MoAbs followed by indirect immunoperoxidase staining. As we were able to show, all chondrocytes reacted with OX17 MoAb detecting Class II (Ia) antigen encoded by the RT1.D subregion of rat major histocompatibility complex (MHC). However, unlike splenocytes they did not react with OX6 MoAb detecting the RT1.B encoded Class II molecule. Moreover, all chondrocytes were stained with W3/25 MoAb specific for the rat equivalent of human CD4 (T4) antigen and with W3/13 MoAb specific for rat leucocyte sialoglycoprotein. A positive reaction was also obtained with the antibody against the S-100 protein. By contrast, chondrocytes did not react with antibodies specific for all T (OX19) or B (HIS14) cells, rat CD8 (T8) equivalent, monocytes/macrophages (ED1, ED2), factor VIII (M616), or glial fibrillary acidic protein (Z334).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784750      PMCID: PMC1541958     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  The stimulation of lymphocytes by chondrocytes in mixed cultures.

Authors:  S D Gertzbein; E M Lance
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

2.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

Authors:  A F Williams; G Galfrè; C Milstein
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen.

Authors:  W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

4.  The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.

Authors:  J P Tite; A Sloan; C A Janeway
Journal:  J Mol Cell Immunol       Date:  1986

5.  Analysis of Ir gene function using monoclonal antibodies: independent regulation of GAT and GLPhe T cell responses by I-A and I-E subregion products on a single accessory cell population.

Authors:  J T Nepom; B Benacerraf; R N Germain
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

6.  Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.

Authors:  T A Gonwa; L J Picker; H V Raff; S M Goyert; J Silver; J D Stobo
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin.

Authors:  D Cocchia; F Michetti; R Donato
Journal:  Nature       Date:  1981-11-05       Impact factor: 49.962

8.  Antigenic profile of the rat chondrocyte.

Authors:  Z M Malseed; S Heyner
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

9.  Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus.

Authors:  T Fukumoto; W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1982-03       Impact factor: 5.532

10.  Demonstration of a new genetic locus in the major histocompatibility system of the rat.

Authors:  S A Lobel; D V Cramer
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

View more
  1 in total

Review 1.  Antigenic and immunogenic properties of chondrocytes. Implications for chondrocyte therapeutic transplantation and pathogenesis of inflammatory and degenerative joint diseases.

Authors:  Anna Osiecka-Iwan; Anna Hyc; Dorota M Radomska-Lesniewska; Adrian Rymarczyk; Piotr Skopinski
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.